The ASH Choosing Wisely® campaign five hematologic tests and treatments to question

SUMMARY: CHOOSING WISELY® is a quality improvement initiative led by the American Board of Internal Medicine Foundation in collaboration with leading medical societies in the United States such as the American Society of Hematology (ASH). This organization was established to improve quality of medical care, after it was noted that about 25% of the tests ordered at the time of hospital admission and 65% of the tests ordered on subsequent days were avoidable. Further, there is ample evidence to suggest that reducing unneeded investigations can decrease costs, increase patient satisfaction and quality of care. CHOOSING WISELY® has challenged medical societies to identify 5 tests, procedures or treatments, within each specialty's clinical domain, that are offered to patients, despite the lack of evidence demonstrating its benefit. The goal is to make positive changes in the actual delivery of patient care. The ASH identified 5 tests and treatments that practicing hematologists should give due consideration to, that in some situations are not evidence based and which in certain cases are associated with risks that outweigh the benefits and are not cost efficient.

Related Posts:

• The Second ASH CHOOSING WISELY® Campaign Five…
• The 2015 ASH CHOOSING WISELY® Campaign Five…
• Choosing Appropriate Therapy in Chronic Myeloid Leukemia
• The FDA recommends against using screening tests for…
• FDA Approves Subcutaneous RITUXAN® Formulation…
• FDA Approves Subcutaneous RITUXAN® Formulation…